Skip to main content

Denali Therapeutics Inc.

DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001714899

In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Denali Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
3 insiders, $435.3K in total
Insiders trading
3
Net value
−$435.3K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Denali Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Denali Therapeutics Inc.
NameTitleLast reported holdingLast filingFilings, past year
Chin Peter ScottChief Medical Officer204,538Sep 9, 20261
Thornberry NancyDirector19,686Sep 4, 20262
Schuth Alexander O.COFO and Secretary278,995Sep 3, 20264
Watts Ryan J.President and CEO2,120,384IndirectAug 14, 20263
Baker JulianDirector3,422,366IndirectJun 5, 20262
Baker FelixDirector3,422,366IndirectJun 5, 20262
Baker Bros. Advisors LPDirector3,422,366IndirectJun 5, 20262
Baker Brothers Life Sciences LPDirector3,422,366IndirectJun 5, 20262
667, L.P.Director3,422,366IndirectJun 5, 20262
Baker Bros. Advisors (GP) LLCDirector3,422,366IndirectJun 5, 20262
Flatley Jay TDirector22,628Jun 5, 20261
Klein Peter SDirector33,941Jun 5, 20261
Schenkein David PDirector21,665Jun 5, 20261
Krognes Steve E.Director38,202Jun 5, 20261
Cook Jennifer E.Director32,483Jun 5, 20261
Van Hauwermeiren TimothyDirector17,040Jun 5, 20262
Ho CaroleChief Medical Officer216,585Aug 14, 20250
Tessier-Lavigne MarcDirector1,886,576Jun 5, 20250
Sato Vicki LDirector107,976Jan 3, 20250
Harris ErikDirector17,052Jun 4, 20240
Cole Douglas G.Director26,564Jun 5, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2023 (view filing)Nov 151 daySato Vicki LDirectorSSale−1.67K$19.13−$31.9K−1.3%126.4K after10b5-1
Oct 18, 2023 (view filing)Oct 162 daysSato Vicki LDirectorSSale−1.67K$20.66−$34.4K−1.3%128.0K after10b5-1
Sep 19, 2023 (view filing)Sep 154 daysSato Vicki LDirectorSSale−1.67K$23.62−$39.3K−1.3%129.7K after2 lots10b5-1
Aug 25, 2023 (view filing)Aug 232 daysSchuth Alexander O.COFO and SecretarySSale−2.52K$23.17−$58.4K−0.5%519.0K after
Aug 25, 2023 (view filing)Aug 232 daysHo CaroleChief Medical OfficerSSale−2.52K$23.22−$58.6K−1.4%182.8K after
Aug 23, 2023 (view filing)Aug 212 daysHo CaroleChief Medical OfficerSSale−2.48K$22.60−$56.0K−1.3%185.3K after
Aug 23, 2023 (view filing)Aug 212 daysSchuth Alexander O.COFO and SecretarySSale−2.48K$22.59−$56.0K−0.5%521.5K after
Aug 23, 2023 (view filing)Aug 212 daysWatts Ryan J.President and CEOSSale−2.31K$22.59−$52.2K−0.1%2.24M after
Aug 23, 2023 (view filing)Aug 212 daysKrognes Steve E.DirectorSSale−1.42K$22.60−$32.1K−1.0%145.8K after
Aug 17, 2023 (view filing)Aug 152 daysSato Vicki LDirectorSSale−1.67K$24.30−$40.5K−1.3%131.4K after10b5-1
Aug 16, 2023 (view filing)Aug 142 daysHo CaroleChief Medical OfficerSSale−2.77K$23.79−$65.9K−1.5%182.8K after10b5-1
Aug 16, 2023 (view filing)Aug 142 daysSchuth Alexander O.COFO and SecretarySSale−2.77K$23.67−$65.6K−0.5%519.0K after
Aug 14, 2023 (view filing)Aug 104 daysWatts Ryan J.President and CEOSSale−2.53K$25.03−$63.2K−0.1%2.24M after
Aug 14, 2023 (view filing)Aug 104 daysHo CaroleChief Medical OfficerSSale−2.86K$24.15−$69.0K−1.5%185.6K after
Aug 14, 2023 (view filing)Aug 104 daysSchuth Alexander O.COFO and SecretarySSale−2.85K$24.18−$69.0K−0.5%521.8K after
Jul 19, 2023 (view filing)Jul 17-182 daysSchuth Alexander O.COFO and SecretarySSale−19.7K$29.80−$587.2K−3.7%519.0K after2 lots
Jul 19, 2023 (view filing)Jul 172 daysSato Vicki LDirectorSSale−1.67K$29.60−$49.3K−1.2%133.0K after10b5-1
Jun 30, 2023 (view filing)Jun 282 daysSato Vicki LDirectorSSale−1.67K$29.84−$49.7K−1.2%134.7K after2 lots10b5-1
Jun 20, 2023 (view filing)Jun 164 daysWatts Ryan J.President and CEOSSale−50.0K$31.40−$1.57M−2.2%2.24M after
May 17, 2023 (view filing)May 152 daysSchuth Alexander O.COFO and SecretarySSale−10.0K$28.60−$286.0K−1.9%528.7K after2 lots
Apr 24, 2023 (view filing)Apr 20-214 daysWatts Ryan J.President and CEOSSale−25.0K$25.15−$628.7K−1.1%2.24M after2 lots
Apr 14, 2023 (view filing)Apr 12-132 daysSchuth Alexander O.COFO and SecretarySSale−10.0K$25.04−$250.4K−1.9%528.7K after2 lots
Feb 17, 2023 (view filing)Feb 152 daysHo CaroleChief Medical OfficerSSale−1.48K$29.40−$43.4K−0.8%182.8K after
Feb 15, 2023 (view filing)Feb 132 daysKrognes Steve E.DirectorSSale−2.12K$30.10−$63.8K−1.5%143.0K after
Feb 15, 2023 (view filing)Feb 132 daysSchuth Alexander O.COFO and SecretarySSale−3.50K$30.09−$105.2K−0.7%528.7K after
Feb 15, 2023 (view filing)Feb 132 daysWatts Ryan J.President and CEOSSale−33.8K$30.08−$1.02M−1.5%2.24M after2 lots
Feb 14, 2023 (view filing)Feb 10-134 daysHo CaroleChief Medical OfficerSSale−3.37K$30.03−$101.1K−1.8%184.3K after2 lots
Feb 13, 2023 (view filing)Feb 9-104 daysWatts Ryan J.President and CEOSSale−28.4K$29.28−$832.5K−1.3%2.23M after2 lots
Feb 10, 2023 (view filing)Feb 82 daysHo CaroleChief Medical OfficerSSale−1.52K$30.88−$47.0K−0.8%180.2K after
Feb 10, 2023 (view filing)Feb 82 daysSchuth Alexander O.COFO and SecretarySSale−1.52K$30.89−$47.0K−0.3%499.9K after
Feb 10, 2023 (view filing)Feb 82 daysKrognes Steve E.DirectorSSale−1.38K$30.88−$42.5K−0.9%145.1K after
Jan 19, 2023 (view filing)Jan 172 daysSchuth Alexander O.COFO and SecretarySSale−10.0K$29.53−$295.3K−2.0%497.2K after2 lots
Jan 10, 2023 (view filing)Jan 91 dayHo CaroleChief Medical OfficerSSale−1.46K$28.48−$41.6K−0.8%177.5K after
Jan 9, 2023 (view filing)Jan 5-64 daysHo CaroleChief Medical OfficerSSale−4.09K$28.52−$116.6K−2.2%178.9K after2 lots
Jan 9, 2023 (view filing)Jan 54 daysKrognes Steve E.DirectorSSale−2.97K$28.44−$84.5K−2.0%146.5K after
Jan 9, 2023 (view filing)Jan 54 daysSchuth Alexander O.COFO and SecretarySSale−2.64K$28.44−$75.0K−0.5%497.2K after
Jan 9, 2023 (view filing)Jan 54 daysWatts Ryan J.President and CEOSSale−4.80K$28.44−$136.5K−0.2%2.22M after
Jan 9, 2023 (view filing)Jan 45 daysSchuth Alexander O.COFO and SecretarySSale−2.91K$28.70−$83.6K−0.6%492.3K afterAmended
Jan 5, 2023 (view filing)Jan 41 dayHo CaroleChief Medical OfficerSSale−2.91K$28.69−$83.6K−1.6%175.5K after
Jan 5, 2023 (view filing)Jan 41 dayWatts Ryan J.President and CEOSSale−5.03K$28.73−$144.5K−0.2%2.21M after
Nov 28, 2022 (view filing)Nov 235 daysTessier-Lavigne MarcDirectorSSale−20.0K$30.48−$609.6K−1.1%1.87M after
Nov 3, 2022 (view filing)Nov 1-22 daysTessier-Lavigne MarcDirectorSSale−20.0K$30.27−$605.5K−1.0%1.89M after2 lots
Sep 30, 2022 (view filing)Sep 282 daysTessier-Lavigne MarcDirectorSSale−20.0K$30.82−$616.3K−1.0%1.91M after2 lots
Aug 25, 2022 (view filing)Aug 232 daysTessier-Lavigne MarcDirectorSSale−20.0K$31.61−$632.3K−1.0%1.93M after2 lots
Aug 25, 2022 (view filing)Aug 232 daysHo CaroleChief Medical OfficerSSale−2.42K$31.98−$77.5K−1.4%170.7K after
Aug 23, 2022 (view filing)Aug 194 daysWatts Ryan J.President and CEOSSale−2.40K$33.22−$79.9K−0.1%2.20M after
Aug 23, 2022 (view filing)Aug 194 daysKrognes Steve E.DirectorSSale−2.25K$33.22−$74.8K−1.5%149.5K after
Aug 23, 2022 (view filing)Aug 194 daysSchuth Alexander O.COFO and SecretarySSale−2.58K$33.22−$85.6K−0.5%467.5K after
Aug 23, 2022 (view filing)Aug 194 daysHo CaroleChief Medical OfficerSSale−2.58K$33.22−$85.6K−1.5%173.1K after
Jul 27, 2022 (view filing)Jul 252 daysTessier-Lavigne MarcDirectorSSale−20.0K$35.61−$712.1K−1.0%1.95M after2 lots